XOVOLTIB 30MG (AFATINIB DIMALEATE)

$930.00$2,330.00

Active Ingredient

Afatinib Dimaleate

Indication

Non-small cell lung cancer

Manufacturer

Boehringer Ingelheim India Pvt.Ltd

Packaging

7 Tablets in 1 strip

Strength

30mg

Delivery Time

6 To 15 days

  • 20% Off Coupan Code GD20
  • Data Privacy and Security
  • Free Shipping on Orders Over $199
Variation Price Quantity Add To Cart
28 Tablet/s $930.00
Add to cart
56 Tablet/s $1,730.00
Add to cart
84 Tablet/s $2,330.00
Add to cart

XOVOLTIB is taken orally, usually once a day, and has been shown to improve outcomes for people with metastatic squamous non-small cell lung cancer. In clinical trials, XOVOLTIB effectively prolongs survival for those with this type of cancer. In addition, those who took it found the drug to be well tolerated, with few side effects reported.

Reviews

There are no reviews yet.

Be the first to review “XOVOLTIB 30MG (AFATINIB DIMALEATE)”

Your email address will not be published. Required fields are marked *